900000000000509007: United States of America English language reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Language type reference set (foundation metadata concept)\English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)\US English

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
US English	Is a	English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	acceptabilityId
Product containing precisely normal human immunoglobulin 100 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely normal human immunoglobulin 160 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely normal human immunoglobulin 50 milligram/1 milliliter conventional release solution for infusion (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely nystatin 100000 unit/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely nystatin 100000 unit/1 each conventional release oromucosal lozenge (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely nystatin 100000 unit/1 milliliter conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely nystatin 500000 unit/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ofloxacin 3 milligram/1 milliliter conventional release eye drops (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ombitasvir 12.5 milligram and paritaprevir 75 milligram and ritonavir 50 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely omeprazole (as omeprazole sodium) 40 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely omeprazole 10 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely omeprazole 10 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely omeprazole 20 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely omeprazole 20 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely omeprazole 4 milligram/1 milliliter conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely omeprazole 40 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely omeprazole 40 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ondansetron (as ondansetron hydrochloride) 2 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ondansetron (as ondansetron hydrochloride) 4 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ondansetron (as ondansetron hydrochloride) 8 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ondansetron (as ondansetron hydrochloride) 800 microgram/1 milliliter conventional release oral solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ondansetron hydrochloride 24 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely oseltamivir (as oseltamivir phosphate) 12 milligram/1 milliliter conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely oseltamivir (as oseltamivir phosphate) 30 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely oseltamivir (as oseltamivir phosphate) 45 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely oseltamivir (as oseltamivir phosphate) 75 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely oxaliplatin 100 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely oxaliplatin 5 milligram/1 milliliter conventional release solution for infusion (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely oxaliplatin 50 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely oxamniquine 250 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely oxycodone hydrochloride 1 milligram/1 milliliter conventional release oral solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely oxycodone hydrochloride 10 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely oxycodone hydrochloride 10 milligram/1 each conventional release orodispersible tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely oxycodone hydrochloride 10 milligram/1 each prolonged-release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely oxycodone hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely oxycodone hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely oxycodone hydrochloride 15 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely oxycodone hydrochloride 15 milligram/1 each prolonged-release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely oxycodone hydrochloride 20 milligram/1 each conventional release orodispersible tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely oxycodone hydrochloride 20 milligram/1 each prolonged-release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely oxycodone hydrochloride 20 milligram/1 milliliter conventional release oral solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely oxycodone hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely oxycodone hydrochloride 30 milligram/1 each prolonged-release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely oxycodone hydrochloride 40 milligram/1 each prolonged-release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely oxycodone hydrochloride 5 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely oxycodone hydrochloride 5 milligram/1 each conventional release orodispersible tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely oxycodone hydrochloride 5 milligram/1 each prolonged-release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely oxycodone hydrochloride 50 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely oxycodone hydrochloride 60 milligram/1 each prolonged-release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely oxycodone hydrochloride 80 milligram/1 each prolonged-release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely oxygen 1 milliliter/1 milliliter conventional release gas for inhalation (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely oxytocin 10 unit/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely paclitaxel 6 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely para-aminosalicylic acid 4 gram/1 sachet gastro-resistant oral granules (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely para-aminosalicylic acid 500 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely paracetamol 100 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely paracetamol 100 milligram/1 each conventional release rectal suppository (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely paracetamol 24 milligram/1 milliliter conventional release oral solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely paracetamol 24 milligram/1 milliliter conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely paracetamol 25 milligram/1 milliliter conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely paracetamol 250 milligram/1 each conventional release rectal suppository (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely pegaspargase 750 unit/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely penicillamine 250 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely penicillamine 250 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely pentamidine isethionate 300 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely permethrin 10 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely permethrin 50 milligram/1 gram conventional release cutaneous cream (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely phenobarbital 100 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely phenobarbital 15 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely phenobarbital 3 milligram/1 milliliter conventional release oral elixir (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely phenobarbital 30 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely phenobarbital 60 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely phenobarbital sodium 200 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely phenoxymethylpenicillin (as phenoxymethylpenicillin potassium) 250 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely phenoxymethylpenicillin (as phenoxymethylpenicillin potassium) 50 milligram/1 milliliter conventional release oral solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely phenytoin 50 milligram/1 each conventional release chewable tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely phenytoin 6 milligram/1 milliliter conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely phenytoin sodium 100 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely phenytoin sodium 100 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely phenytoin sodium 25 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely phenytoin sodium 50 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely phenytoin sodium 50 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely phenytoin sodium 50 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely phospholipid (as beractant) 25 milligram/1 milliliter conventional release suspension for endotracheopulmonary instillation (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely phytomenadione 10 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely phytomenadione 10 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely phytomenadione 2 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely pilocarpine hydrochloride 20 milligram/1 milliliter conventional release eye drops (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye drops (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely pilocarpine nitrate 20 milligram/1 milliliter conventional release eye drops (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely piperacillin (as piperacillin sodium) 2 gram and tazobactam (as tazobactam sodium) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely piperacillin (as piperacillin sodium) 4 gram and tazobactam (as tazobactam sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely plazomicin (as plazomicin sulfate) 50 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely podophyllotoxin 5 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely polygeline 35 milligram/1 milliliter conventional release solution for infusion (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely polymyxin B (as polymyxin B sulfate) 500000 unit/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely poractant alfa 80 milligram/1 milliliter conventional release suspension for endotracheopulmonary instillation (clinical drug)	Preferred (foundation metadata concept)

Start Previous Page 412 of 579 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001115012	United States of America English language reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	IPS terminology module (core metadata concept)
900000000001116013	US English	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	IPS terminology module (core metadata concept)
900000000001117016	United States of America English language reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	IPS terminology module (core metadata concept)